EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:233197 |
| ChEBI Name | devimistat |
| Stars | |
| Definition | A racemate comprising equimolar amounts of (6R)-6,8-bis(benzylsulfanyl)octanoic acid and its enantiomer, (6S)-6,8-bis(benzylsulfanyl)octanoic acid. It is an inhibitor of pyruvate dehydrogenase and α-ketoglutarate dehydrogenase enzymes, and currently in development for the treatment of pancreatic cancer and acute myeloid leukemia. |
| Last Modified | 3 April 2025 |
| Submitter | FlyBase |
| Formula | C22H28O2S2 |
| Net Charge | 0 |
| Average Mass | 388.598 |
| Monoisotopic Mass | 388.15307 |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of pyruvate dehydrogenase (acetyl-transferring) kinase (EC 2.7.11.2). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| devimistat (CHEBI:233197) has part (6R)-6,8-bis(benzylsulfanyl)octanoic acid (CHEBI:233959) |
| devimistat (CHEBI:233197) has part (6S)-6,8-bis(benzylsulfanyl)octanoic acid (CHEBI:233960) |
| devimistat (CHEBI:233197) has role antineoplastic agent (CHEBI:35610) |
| devimistat (CHEBI:233197) has role EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor (CHEBI:176961) |
| devimistat (CHEBI:233197) is a racemate (CHEBI:60911) |
| INNs | Source |
|---|---|
| dévimistat | WHO MedNet |
| devimistatum | WHO MedNet |
| devimistat | WHO MedNet |
| devimistat | WHO MedNet |
| Synonyms | Source |
|---|---|
| CPI-613 | SUBMITTER |
| CPI 613 | ChEBI |
| CPI613 | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| DB12109 | DrugBank |
| Devimistat | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:95809-78-2 | ChEBI |
| Citations |
|---|